QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Dr. Michael S. Leapman is one of the nation’s leading prostate cancer specialists and researchers. He is widely recognized for his work to improve the diagnosis, treatment, and long-term care of men with prostate cancer. Education, Training, and Appointments…
One of the longest-running prostate cancer screening studies has now followed more than 160,000 men for over two decades, providing valuable information about the long-term benefits of PSA screening. Researchers found that men invited to regular PSA screening were…
Many men undergo an MRI after a prostate biopsy fails to detect cancer, but PSA levels remain elevated. However, MRI scans are expensive and are not always necessary. Researchers studied more than 250 men who previously had a negative prostate…
Black men in the United States have historically experienced higher rates of prostate cancer death than men of other racial and ethnic groups. Researchers have long questioned how much of this difference is related to biology versus differences in…
Magnetic resonance imaging (MRI) has become an important part of prostate cancer diagnosis, but many MRI scans do not detect significant cancer. Researchers are looking for better ways to identify which men are most likely to benefit from MRI. In…
Prostate cancer remains the most diagnosed cancer in American men other than skin cancer, the second-leading cause of cancer death in males after lung cancer, and the number of men diagnosed with advanced disease has been increasing in recent…
Understanding a prostate biopsy report can be difficult for many patients. Medical terminology and pathology reports often contain unfamiliar language that can make an already stressful situation even more confusing. Researchers investigated whether ChatGPT-4 could translate prostate biopsy reports into…
Scientists continue to explore whether inherited genetic information can improve prostate cancer screening and help identify men at greatest risk. This study evaluated a polygenic risk score—a test that combines hundreds of inherited genetic variations—in more than 98,000 participants from…
Some men develop a small number of cancerous lymph nodes after initial treatment for prostate cancer. Doctors have debated whether it is better to treat only the visible lymph nodes or to treat the entire pelvic lymph node region with…
Magnetic resonance imaging (MRI) has become an important tool for diagnosing prostate cancer. However, the standard MRI examination is relatively time-consuming, expensive, and requires the use of an intravenous contrast dye. Researchers from 22 medical centers in 12 countries studied…
"*" indicates required fields
